Rapport Therapeutics Funding & Investors
Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, and trust.
rapportrx.comTotal Amount Raised: $250,000,000
Rapport Therapeutics Funding Rounds
IPO
Unknown
Series B
$150,000,000
Series B Investors
Cormorant Asset ManagementArch Venture PartnersFidelity InvestmentsLogos Global ManagementThird Rock VenturesPerceptive AdvisorsGoldman Sachs Asset ManagementSurveyor CapitalJohnson & Johnson Innovation – JJDCSofinnovaT. Rowe PriceSeries A
$100,000,000
Series A Investors
Third Rock VenturesArch Venture PartnersJohnson & Johnson Innovation – JJDC
Funding info provided by Diffbot.